DeepMed Research

The University Of Texas Health Science Center At San Antonio

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effect of Gender Affirming Hormone Therapy on Glucose Metabolism

Early Phase 1

Recruiting

Conditions: Transgender Persons

Interventions: Drug: Botnia Clamp
Other: Withdrawal of Gender Affirming Hormone Therapy (GAHT)

First Posted Date: 2020-08-17

Last Posted Date: 2024-07-09

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 60

Registration Number: NCT04515472

Locations: 🇺🇸
Bartter Clinical Research Unit, Audie L. Murphy VA Hospital, sTXVHCS, San Antonio, Texas, United States

Clinical Trial to Decrease Length of Stay in Infants With Neonatal Abstinence Syndrome With an Exclusive Human Milk Diet

Not Applicable

Active, not recruiting

Conditions: Neonatal Abstinence Syndrome

Interventions: Other: Standard of Care
Other: Human Milk

First Posted Date: 2020-08-11

Last Posted Date: 2025-05-21

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 19

Registration Number: NCT04508348

Locations: 🇺🇸
University Health System, Robert B Green, San Antonio, Texas, United States
🇺🇸
MARC - The University of Texas Health Science Center, San Antonio, Texas, United States

Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS

Phase 1

Withdrawn

Conditions: Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
Respiratory Failure
Sars-CoV2

Interventions: Drug: Placebo
Drug: Rapamycin

First Posted Date: 2020-07-22

Last Posted Date: 2021-06-01

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Registration Number: NCT04482712

Locations: 🇺🇸
University Hospital System, San Antonio, Texas, United States
🇺🇸
Audie L Murphy Memorial Veterans Hospital, San Antonio, Texas, United States

Effect of Behavioral Lifestyle Intervention on Frailty in Older Adults With Diabetes

Not Applicable

Completed

Conditions: Frailty
Type 2 Diabetes
Weight, Body

Interventions: Behavioral: Lifestyle App
Behavioral: Look AHEAD behavior lifestyle intervention
Behavioral: Abbreviated Look AHEAD behavior lifestyle intervention

First Posted Date: 2020-06-19

Last Posted Date: 2022-05-24

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 20

Registration Number: NCT04440449

Locations: 🇺🇸
The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer

Phase 2

Terminated

Conditions: Urinary Bladder Neoplasms

Interventions: Drug: AGEN1884
Drug: AGEN2034
Drug: Cisplatin
Drug: Gemcitabine

First Posted Date: 2020-06-12

Last Posted Date: 2024-04-04

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 4

Registration Number: NCT04430036

Locations: 🇺🇸
Mays Cancer Center, San Antonio, Texas, United States

Learning Skills Together Pilot Study

Not Applicable

Completed

Conditions: Intervention
Complex Care
Family Caregiving
Self Efficacy

Interventions: Behavioral: Learning Skills Together

First Posted Date: 2020-06-11

Last Posted Date: 2023-03-21

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 41

Registration Number: NCT04428034

Locations: 🇺🇸
UT Health San Antonio, San Antonio, Texas, United States

Testing the Bioavailability of Phytonutrients, Curcumin and Ursolic Acid

Early Phase 1

Completed

Conditions: Bioavailability of Phytonutrients

Interventions: Drug: Curcumin
Drug: Ursolic Acid

First Posted Date: 2020-06-09

Last Posted Date: 2021-05-05

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 18

Registration Number: NCT04421716

Locations: 🇺🇸
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Antibiotic Selection Using Next Generation Sequencing vs Urine Culture

Not Applicable

Completed

Conditions: Renal Stone
Infection, Bacterial
Kidney Stone

Interventions: Other: NGS + Antibiotic Recommendation
Procedure: Standard of Care treatment

First Posted Date: 2020-05-28

Last Posted Date: 2024-03-12

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 240

Registration Number: NCT04404855

Locations: 🇺🇸
Audie Murphy VA Hospital, San Antonio, Texas, United States
🇺🇸
The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center, San Antonio, Texas, United States
🇺🇸
University Health System, San Antonio, Texas, United States

Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate

Early Phase 1

Withdrawn

Conditions: Prostate Cancer

Interventions: Drug: Ursolic Acid
Drug: Curcumin

First Posted Date: 2020-05-27

Last Posted Date: 2021-09-16

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Registration Number: NCT04403568

Locations: 🇺🇸
Mays Cancer Center, San Antonio, Texas, United States

SGLT2 Inhibition in Older Obese Adults With Pre-diabetes

Phase 1

Completed

Conditions: Aging

Interventions: Drug: Dapagliflozin 10 mg
Behavioral: Nutritional counseling

First Posted Date: 2020-05-26

Last Posted Date: 2024-01-05

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 20

Registration Number: NCT04401904

Locations: 🇺🇸
Texas Diabetes Institute - University Health System, San Antonio, Texas, United States
🇺🇸
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy